450960
Lutetium(III) chloride
anhydrous, powder, 99.99% trace metals basis
Synonym(s):
Lutetium chloride, Lutetium trichloride
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
grade
anhydrous
Assay
99.99% trace metals basis
form
powder
reaction suitability
reagent type: catalyst
core: lutetium
impurities
≤150.0 ppm Trace Rare Earth Analysis
mp
905 °C (lit.)
density
3.98 g/mL at 25 °C (lit.)
SMILES string
Cl[Lu](Cl)Cl
InChI
1S/3ClH.Lu/h3*1H;/q;;;+3/p-3
InChI key
AEDROEGYZIARPU-UHFFFAOYSA-K
Application
Lutetium(III) chloride can be used:
- As a precursor to synthesize chiral bridged lutetium catalyst for asymmetric hydroamination.
- As a starting material to prepare doped lutetium oxide nanophosphors.
- To fabricate scintillation detectors such as lutetium aluminum garnet (LuAG).
accessory
Product No.
Description
Pricing
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Cancer biotherapy & radiopharmaceuticals, 32(10), 364-370 (2017-12-22)
The primary objective of this investigation is the development of a strategy for the synthesis of polyhydroxamic acid (PHA)-grafted cellulose film, its characterization, and evaluation of its usefulness for the preparation of
Cancer biotherapy & radiopharmaceuticals, 34(5), 306-315 (2019-06-13)
Background: Transarterial radioembolization (TARE) represents an effective targeted therapeutic option for hepatocellular carcinoma (HCC), a cancer with high mortality
Physical chemistry chemical physics : PCCP, 22(18), 10063-10075 (2020-04-28)
In the present work, the effect of doping on electronic properties in bulk purified and filled arc-discharge single-walled carbon nanotubes samples is studied for the first time by in situ Raman spectroelectrochemical method. A major challenge to turn the potential
Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
Molecular pharmaceutics, 11(9), 3090-3096 (2014-08-01)
Radioimmunotherapy (RIT) of solid tumors is hampered by low tumor-to-nontumor (T/NT) ratios of the radiolabeled monoclonal antibodies resulting in low tumor doses in patients. Pretargeting technologies can improve the effectiveness of RIT in cancer therapy by increasing this ratio. We
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(9), 1422-1428 (2015-07-15)
Radioimmunotherapy and nuclear imaging (immuno-PET/SPECT) of cancer with radiometal-labeled antibody fragments or peptides is hampered by low tumor-to-kidney ratios because of high renal radiometal retention. Therefore, we developed and evaluated a pretargeting strategy using click chemistry in vivo to reduce
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service